Virtually Live: 2nd October 2024

·21 min·2 clips

Pro Medicus wins every contract it tenders for, with 100% retention and 70% gross margins, yet trades at 220 times earnings.

The episode is a solo Q&A format where host Shannon Rifkin responds to viewer questions submitted to the Virtually Live Local show. Rifkin opens with a brief market overview, noting recent consolidation after strong gains since October 2023. The first question concerns Metalhawk (MHK), a small gold explorer with a $15 million market cap and $2 million cash; Rifkin explains the sector's high failure rate and reliance on luck or takeovers. Next, Fiberic Pharma is discussed, a $6-7 million company marketing an antiviral nasal spray in the U.S.; Rifkin highlights its regulatory progress but worries about cash burn and lack of marketing expertise. Multiple questions follow on Woodside, focusing on its 11% profit increase, dividend cuts, and recent $4-5 billion acquisitions into clean energy; Rifkin notes shareholder dissatisfaction and the stock's sell-off despite attractive yields. A final question covers Pro Medicus (PME), a SaaS medical imaging company that has risen from $30 to $180; Rifkin details its 10% U.S. market share, 100% client retention, 70% gross margins, and 30% annual growth, advising against selling solely due to its high PE ratio. Throughout, Rifkin stresses themes of cash management, risk assessment, and long-term portfolio alignment.

As heard by us

A clear market Q&A on gold explorers, Woodside's transition choices, dividends, and portfolio discipline after a strong run.

Shannon Rifkin's 2 October market Q&A reads a market that may have reached a ceiling after a spectacular run, then turns to the practical questions sitting beneath that pause.

Read the full review in PlayNext →

Why you'd press play

You want a market check that moves from recent consolidation to Metalhawk's gold-price disconnect and Woodside's shareholder-return debate.

Read the full recommendation in PlayNext →

Listen to the show on

Apple Podcasts Spotify

Play clips from this episode More from Rivkin Investment Podcast